Ask AI
ProCE Banner Activity

Nursing Strategies to Optimize SGLT2 Inhibitors in Heart Failure: Experts Answer Your Questions

Clinical Thought

Take home expert-informed nursing strategies to better integrate SGLT inhibitors in heart failure care as a key component of guideline-directed medical therapy, including how nurses can help with follow-up and considerations for when to initiate, pause, or discontinue therapy.

Released: July 08, 2025

Expiration: July 07, 2026

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners).

ProCE Banner

Supporters

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company

Disclosure

Primary Author

Midge Bowers, DNP, FNP-BC, FAANP, FAAN, FACC, has no relevant financial relationships to disclose.

Stephen J. Greene, MD: consultant/advisor/speaker: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Chugai, Corcept, CSL Vifor, Idorsia, Lexicon, Lilly, Merck, Novo Nordisk, Otsuka, Roche Diagnostics, Recordati, Sanofi, SCPharmaceuticals, Sumitomo, Tricog Health; researcher: Bayer, Boehringer Ingelheim, Novartis.